Clinical Trial Update: A Clinical Trial Evaluating the Effect of Pharmacological Ascorbate on Radiation Therapy for Pancreatic Cancer Patients [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating pharmacological ascorbate in combination with radiation therapy for pancreatic cancer has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• Pharmacological ascorbate (ascorbate)

Snippet

Sponsor: Joseph J. Cullen, MD, FACS | Conditions: Pancreatic Neoplasm | Phase 2 | Status: WITHDRAWN